BSEColinz Laboratories Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 18 Jun, 2026 · 17:13 IST

Open offer public announcement filed for Colinz Laboratories

Open Offer TriggeredStrategic Transactions View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.4%Reaction day
₹59.00
prior close
₹62.18
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+4.6% vs market
Pharmaceuticals peers, median of 160sector+0.4%+5.0% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.4+0.8+4.6+0.4+5.0
Next day
+10.6+1.7+9.0+0.5+10.1
2d
+16.2+0.9+15.2+1.7+14.5
3d
+22.0+0.8+21.1+1.7+20.2
4d
+28.1+0.2+27.8+0.9+27.1
5d
+34.4-0.1+34.5+1.5+33.0
1w
+47.4+1.1+46.3+2.7+44.7
15d
+22.0+2.5+19.5+4.1+17.9
1m
+35.5+1.2+34.3+4.0+31.5
2m
+35.6+4.9+30.7+2.0+33.6
3m
+26.6+5.8+20.8+7.7+18.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Saffron Capital Advisors Private Limited, acting as Manager to the Offer, has submitted a Public Announcement to BSE under SEBI Takeover Regulations 3(1) and 4 read with Regulations 13, 14 and 15(1). This filing indicates an open offer has been formally triggered for Colinz Laboratories, likely following a substantial acquisition of shares or change in control. Further details on offer price, size and timeline are expected in the detailed letter of offer.

Likely market impact

Shareholders may get an exit opportunity at a prescribed offer price; expect price volatility and watch for the detailed letter of offer.